Keyphrases
Subretinal Drusenoid Deposits
100%
Fovea
76%
Adverse Events
58%
Uveitis
57%
Choroidal Thickness
52%
Retinal Vein Occlusion
50%
Anti-vascular Endothelial Growth Factor Therapy
50%
Programmed Death-ligand 1 (PD-L1)
50%
Immune Checkpoint Inhibitors
50%
Time-to-treatment
50%
Geographic Atrophy
50%
Natural History
50%
Vitreoretinal
50%
Vascular Disease
47%
Visual Acuity
46%
Best-corrected Visual Acuity
43%
Confidence Interval
43%
High Risk
40%
Age-related Macular Degeneration
35%
Endophthalmitis
34%
Cardiovascular Disease
34%
Right Eye
33%
Photoreceptor
33%
Adaptive Optics Ophthalmoscopy
33%
Panuveitis
32%
Pars Plana Vitrectomy
32%
Left Eye
31%
Proliferative Diabetic Retinopathy
31%
Carotid Artery Stenosis
30%
Aflibercept
30%
Neovascular Age-related Macular Degeneration (nAMD)
30%
Diabetic Retinopathy
30%
Optical Coherence Tomography Angiography (OCT-A)
29%
Soft Drusen
27%
Five Eyes
27%
Meta-analysis
26%
Systematic Meta-analysis
26%
Ocular Involvement
26%
Solar Retinopathy
25%
Central Serous Chorioretinopathy
25%
Lymphoproliferative Disorders
25%
AI Chatbot
25%
Scleral Buckling
25%
Amniotic Membrane
25%
Pneumatic Displacement
25%
Cardiovascular Events
25%
Subretinal Recombinant Tissue Plasminogen Activator
25%
Submacular Hemorrhage
25%
Performance Assessment
25%
Degenerative Disease
25%
Medicine and Dentistry
Vascular Disease
81%
Optical Coherence Tomography
73%
Visual Acuity
63%
Descemet Stripping Endothelial Keratoplasty
50%
Geographic Atrophy
50%
Time to Treatment
50%
Glaucoma
38%
Photoreceptor Cell
37%
Age Related Macular Degeneration
35%
Endophthalmitis
34%
Ophthalmoscopy
33%
Pars Plana Vitrectomy
32%
Vasculotropin
31%
Cross Sectional Study
30%
Carotid Artery Stenosis
30%
Internal Carotid Artery
30%
Bleeding
29%
Optical Coherence Tomography Angiography
28%
Retinopathy
28%
Wet Macular Degeneration
28%
Phacoemulsification
25%
Janus Kinase 2
25%
Amnion
25%
Cardiovascular Disease
25%
Subgroup Analysis
25%
Lymphoproliferative Disease
25%
Dexamethasone
25%
Sclera Buckling Procedure
25%
Central Serous Retinopathy
25%
Cataract
25%
Uveitis
25%
Retina Vein Occlusion
25%
Diabetic Retinopathy
25%
Retinopexy
25%
Obstructive Sleep Apnea
25%
Eye Fundus Albipunctatus
25%
Central Retinal Artery Occlusion
25%
Diabetic Macular Edema
25%
Scurvy
25%
Tissue Plasminogen Activator
25%
Medicare
25%
Implant
25%
Macular Hole
25%
Proliferative Vitreoretinopathy
25%
Tamponade
25%
Fungemia
25%
Tertiary Care
25%
Retinal Detachment
24%
Agents Acting on the Eye
22%
Congenital Cornea Dystrophy
18%